Publication: Chloroquine in idiopathic pulmonary hemosiderosis - A case report
dc.contributor.buuauthor | Meral, Adalet | |
dc.contributor.buuauthor | Günay, Ünsal | |
dc.contributor.buuauthor | Küçükerdoğan, Aygün | |
dc.contributor.buuauthor | Canıtez, Yakup | |
dc.contributor.buuauthor | Özuysal, Sema | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı. | tr_TR |
dc.contributor.scopusid | 6602571317 | tr_TR |
dc.contributor.scopusid | 6603885274 | tr_TR |
dc.contributor.scopusid | 6508083721 | tr_TR |
dc.contributor.scopusid | 8988954700 | tr_TR |
dc.contributor.scopusid | 56616314600 | tr_TR |
dc.date.accessioned | 2021-12-10T06:29:50Z | |
dc.date.available | 2021-12-10T06:29:50Z | |
dc.date.issued | 1997 | |
dc.description.abstract | This report describes an 11-year-old boy with idiopathic pulmonary hemosiderosis. His only presenting symptom was severe anemia due to Iron deficiency. Idiopathic pulmonary hemosiderosis was diagnosed nine years after the onset of symptoms. During this period many invasive and non-contributory investigations were performed. This report describes the patient's diagnostic problems, clinical features and dramatic improvement with chloroquine (250 mg/day) after failing to respond to megadose methylprednisolone (30 mg/kg). One year later, chloroquine was discontinued. The patient has remained in remission since March 1994. Chloroquine should be used for this life-threatening conditon since a is less toxic than other immunosuppressive drugs. | en_US |
dc.identifier.citation | Meral, A. vd. (1997). "Chloroquine in idiopathic pulmonary hemosiderosis - A case report". Turkish Journal of Pediatrics, 39(1), 111-115.. | en_US |
dc.identifier.endpage | 115 | tr_TR |
dc.identifier.issn | 0041-4301 | |
dc.identifier.issue | 1 | tr_TR |
dc.identifier.pubmed | 10868202 | tr_TR |
dc.identifier.scopus | 2-s2.0-0031046514 | tr_TR |
dc.identifier.startpage | 111 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/23150 | |
dc.identifier.volume | 39 | tr_TR |
dc.identifier.wos | A1997WK86700017 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.trdizin | TrDizin | tr_TR |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Türkiye Milli Pediatri Derneği | tr_TR |
dc.relation.journal | The Turkish Journal of Pediatrics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Iron-deficiency anemia | en_US |
dc.subject | Idiopathic pulmonary hemosiderosis | en_US |
dc.subject | Chloroquine | en_US |
dc.subject | Cyclophosphamide | en_US |
dc.subject.emtree | Chloroquine | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Idiopathic disease | en_US |
dc.subject.emtree | Iron deficiency anemia | en_US |
dc.subject.emtree | Lung hemosiderosis | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Oral drug administration | en_US |
dc.subject.emtree | School child | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.mesh | Anemia, iron-deficiency | en_US |
dc.subject.mesh | Anti-Inflammatory agents | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Chloroquine | en_US |
dc.subject.mesh | Diagnostic errors | en_US |
dc.subject.mesh | Hemosiderosis | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lung diseases | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.scopus | Lung Hemosiderosis; Hemoptysis; Gluten-Free Diet | en_US |
dc.subject.wos | Pediatrics | en_US |
dc.title | Chloroquine in idiopathic pulmonary hemosiderosis - A case report | en_US |
dc.type | Article | |
dspace.entity.type | Publication |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: